Literature DB >> 17163398

Immunohistochemical characterization of Fas (CD95) and Fas Ligand (FasL/CD95L) expression in the injured brain: relationship with neuronal cell death and inflammatory mediators.

M B Grosjean1, P M Lenzlinger, P F Stahel, I Yatsiv, E Shohami, O Trentz, T Kossmann, M C Morganti-Kossmann.   

Abstract

Traumatic brain injury causes progressive tissue atrophy and consequent neurological dysfunction, resulting from neuronal cell death in both animal models and patients. Fas (CD95) and Fas ligand (FasL/CD95L) are important mediators of apoptosis. However, little is known about the relationship between Fas and FasL and neuronal cell death in mice lacking the genes for inflammatory cytokines. In the present study, double tumor necrosis factor/lymphotoxin-alpha knockout (-/-) and interleukin-6-/- mice were subjected to closed head injury (CHI) and sacrificed at 24 hours or 7 days post-injury. Consecutive brain sections were evaluated for Fas and FasL expression, in situ DNA fragmentation (terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labeling; TUNEL), morphologic characteristics of apoptotic cell death and leukocyte infiltration. A peak incidence of TUNEL positive cells was found in the injured cortex at 24 hours which remained slightly elevated at 7 days and coincided with maximum Fas expression. FasL was only moderately increased at 24 hours and showed maximum expression at 7 days. A few TUNEL positive cells were also found in the ipsilateral hippocampus at 24 hours. Apoptotic, TUNEL positive cells mostly co-localized with neurons and Fas and FasL immunoreactivity. The amount of accumulated polymorphonuclear leukocytes and CD11b positive cells was maximal in the injured hemispheres at 24 hours. We show strong evidence that Fas and FasL might be involved in neuronal apoptosis after CHI. Furthermore, Fas and FasL upregulation seems to be independent of neuroinflammation since no differences were found between cytokine-/- and wild-type mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17163398     DOI: 10.14670/HH-22.235

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  9 in total

Review 1.  Histone deacetylase inhibitors as therapeutic agents for acute central nervous system injuries.

Authors:  Na'ama A Shein; Esther Shohami
Journal:  Mol Med       Date:  2011-01-25       Impact factor: 6.354

Review 2.  Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury.

Authors:  Jenna M Ziebell; Maria Cristina Morganti-Kossmann
Journal:  Neurotherapeutics       Date:  2010-01       Impact factor: 7.620

3.  Newborn screening for autism: in search of candidate biomarkers.

Authors:  Gerald J Mizejewski; Barbara Lindau-Shepard; Kenneth A Pass
Journal:  Biomark Med       Date:  2013-04       Impact factor: 2.851

4.  Mice Lacking Functional Fas Death Receptors Are Protected from Kainic Acid-Induced Apoptosis in the Hippocampus.

Authors:  Miren Ettcheto; Felix Junyent; Luisa de Lemos; Merce Pallas; Jaume Folch; Carlos Beas-Zarate; Ester Verdaguer; Raquel Gómez-Sintes; José J Lucas; Carme Auladell; Antoni Camins
Journal:  Mol Neurobiol       Date:  2014-08-15       Impact factor: 5.590

5.  Tumor necrosis factor alpha and Fas receptor contribute to cognitive deficits independent of cell death after concussive traumatic brain injury in mice.

Authors:  Jugta Khuman; William P Meehan; Xiaoxia Zhu; Jianhua Qiu; Ulrike Hoffmann; Jimmy Zhang; Eric Giovannone; Eng H Lo; Michael J Whalen
Journal:  J Cereb Blood Flow Metab       Date:  2010-10-13       Impact factor: 6.200

6.  Fas ligand interactions contribute to CD8+ T-cell-mediated control of West Nile virus infection in the central nervous system.

Authors:  Bimmi Shrestha; Michael S Diamond
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

7.  CD38 facilitates recovery from traumatic brain injury.

Authors:  Ayelet Levy; Adi Bercovich-Kinori; Alexander G Alexandrovich; Jeanna Tsenter; Victoria Trembovler; Frances E Lund; Esther Shohami; Reuven Stein; Lior Mayo
Journal:  J Neurotrauma       Date:  2009-09       Impact factor: 5.269

8.  Histone deacetylase inhibitor ITF2357 is neuroprotective, improves functional recovery, and induces glial apoptosis following experimental traumatic brain injury.

Authors:  Na'ama A Shein; Nikolaos Grigoriadis; Alexander G Alexandrovich; Constantina Simeonidou; Athanasios Lourbopoulos; Eleni Polyzoidou; Victoria Trembovler; Paolo Mascagni; Charles A Dinarello; Esther Shohami
Journal:  FASEB J       Date:  2009-09-01       Impact factor: 5.191

9.  Clinical-pathological study on β-APP, IL-1β, GFAP, NFL, Spectrin II, 8OHdG, TUNEL, miR-21, miR-16, miR-92 expressions to verify DAI-diagnosis, grade and prognosis.

Authors:  Enrica Pinchi; Alessandro Frati; Luigi Cipolloni; Mariarosaria Aromatario; Vittorio Gatto; Raffaele La Russa; Alessandro Pesce; Alessandro Santurro; Flavia Fraschetti; Paola Frati; Vittorio Fineschi
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.